According to Amedisys's latest financial reports the company's current earnings (TTM) are $39.62 M. In 2022 the company made an earning of $0.16 B a decrease over its 2021 earnings that were of $0.28 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $39.62 M | -75.27% |
2022 | $0.16 B | -42.82% |
2021 | $0.28 B | 32.92% |
2020 | $0.21 B | 23.71% |
2019 | $0.17 B | 7.18% |
2018 | $0.15 B | 96.76% |
2017 | $80.8 M | 31.24% |
2016 | $61.56 M | -20088.96% |
2015 | -$0.31 M | -101.47% |
2014 | $20.97 M | -113.61% |
2013 | -$0.16 B | 30.44% |
2012 | -$0.12 B | -74.94% |
2011 | -$0.48 B | -354.11% |
2010 | $0.18 B | -16.55% |
2009 | $0.22 B | 57.33% |
2008 | $0.14 B | 36.68% |
2007 | $0.10 B | 67.08% |
2006 | $61.89 M | 26.99% |
2005 | $48.74 M | 46.11% |
2004 | $33.35 M | 144.8% |
2003 | $13.62 M | -638.19% |
2002 | -$2.54 M | -128.71% |
2001 | $8.81 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
LHC Group LHCG | $77.2 M | 94.86% | ๐บ๐ธ USA |
National Healthcare
NHC | $89.06 M | 124.77% | ๐บ๐ธ USA |
Chemed CHE | $0.35 B | 792.10% | ๐บ๐ธ USA |